CNVIF (Conavi Medical) Moat Score: 4/10 (As of Jul. 12, 2026)


CNVIF Conavi Medical Corp CNVIF
4 GF Score
Price $0.17
! 5 Warning Signs
View Full Analysis

What is Conavi Medical Moat Score?

Conavi Medical CNVIF 4 Moat Score is 4 as of Jul. 12, 2026. GuruFocus rates CNVIF with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 843 Medical Devices & Instruments companies, Conavi Medical ranks better than 83.27% on this metric.

Conavi Medical has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Conavi Medical has Narrow Moat: Conavi Medical Corp has a modest moat due to its specialized medical technology and some proprietary patents. However, it lacks strong market leadership, customer loyalty, and significant regulatory barriers to elevate it beyond a narrow moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Conavi Medical might have Narrow Moat - Discernible but modest moat.

Conavi Medical  (OTCPK:CNVIF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Conavi Medical Moat Score Related Terms

CNVIF vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Conavi Medical's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Conavi Medical Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conavi Medical's Moat Score distribution charts can be found below:

* The bar in red indicates where Conavi Medical's Moat Score falls into.


CNVIF
4GF Score
Conavi Medical Corp CNVIF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Conavi Medical (CNVIF) has a Moat Score of 4 as of Jul. 12, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Conavi Medical ranks #141 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Conavi Medical's Moat Score too high?
Conavi Medical's current Moat Score is 4. Based on the distribution chart, Conavi Medical ranks #141 out of 843 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Conavi Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Conavi Medical's Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Conavi Medical ranks #141 out of 843 companies for Moat Score. This places Conavi Medical in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Conavi Medical's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conavi Medical stock overvalued right now?
Conavi Medical (CNVIF) has a current Moat Score of 4. The current Moat Score is 4. Conavi Medical's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Conavi Medical (CNVIF), the current Moat Score is 4 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Conavi Medical Business Description

Other Exchanges CNVI:Canada
Address 293 Lesmill Road, Toronto, ON, CAN, M3B 2V1
Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.
4GF Score

Get the complete analysis for CNVIF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price